Welcome to Neoventa, a global life science company!

Neoventa Medical AB is a Swedish medical device company founded in 1997. We are a provider of innovative fetal monitoring solutions and services that improve obstetric care. Our solutions are designed to promote patient safety through enhanced decision making together with structured workflow. Every day, across the globe in over 600 obstetric centers, health care professionals use our unique solutions to ensure a good start in life.

Our core competence lies in using the Stan fetal monitor to perform evidence-based ST Analysis of the fetal ECG as an adjunct to cardiotocography (CTG) during childbirth. We are also the provider of disposable fetal scalp electrodes for internal fetal monitoring under the brand Goldtrace. Another area of business is a comprehensive education and training program, Neoventa Academy, including e-learning with certification.

Numerous studies have shown that ST Analysis as an adjunct to EFM during labor reduces the number of babies born with risk of neurological damage, results in fewer operative deliveries and the need for less fetal blood sampling while at the same time being cost effective. The Stan fetal monitor has been used to deliver over one million children since its introduction in Europe, and over 15,000 patients have been enrolled in randomized trials and over 100,000 patients have been enrolled in observational studies.

Ulf Järnberg
CEO
+46 31 758 32 00
info@neoventa.com.

Neoventa maintains a quality system that meets the requirements of MDD 93/42/EEC, ISO 13485:2016 and FDA regulations.

The Stan fetal monitor holds a PMA approval and is CE marked.

Our head office is located in Gothenburg, Sweden.

Organization number: 556773-4784
VAT number: SE556773478401


About this website
If you have questions regarding this website, please send an e-mail to  info@neoventa.comSTAN™ and Goldtrace™ are trademarks of Neoventa Medical AB.

 

# #